Le Lézard
Classified in: Business
Subjects: MAV, FOR, CFG

/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Thursday, July 20, 2023/


OTTAWA, ON, July 19, 2023 /CNW/ -

Note: All times local

Aspen, Colorado, United States of America



The Deputy Prime Minister will participate in the 14th Aspen Security Forum.



The event will be streamed live via the following link: https://www.youtube.com/watch?v=axPV2RB6frQ



The Deputy Prime Minister will hold bilateral meetings with U.S. and international partners throughout the day.



7:15 p.m.

The Deputy Prime Minister will host a working dinner at the Aspen Security Forum.




Closed to media.


This document is also available at https://deputypm.canada.ca/en

SOURCE Deputy Prime Minister's Office


These press releases may also interest you

at 22:00
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...

at 21:35
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....

at 21:05
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...

at 21:01
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 21:00
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful...

at 20:55
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...



News published on and distributed by: